AIxCrypto Holdings, Inc. (AIXC): debt financing — Qualigen Therapeutics issues $3.3M 8% convertible debenture and warrant to Alpha Capital

AIxCrypto Holdings, Inc.

Issued $3.3M principal debenture for $3M purchase price; 8% interest starts Dec 2023, payable quarterly.
Conversion price $1.32/share; warrant for 2.5M shares at exercise price $1.65, exercisable from June 2023 to June 2028.
Proceeds to advance QN-302 IND candidate toward clinical trials and for working capital.
Monthly redemption of $110k+ interest begins June 2023, with optional redemption at 105% of principal.
Debenture and warrant unregistered, issued under Section 4(a)(2) exemption; registration rights agreement filed.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

AIxCrypto Holdings, Inc. incurred convertible notes of $3,300,000 with Alpha Capital Anstalt at 8% per annum maturing December 22, 2025.

Instrument: convertible notes
Principal: $3,300,000
Counterparty: Alpha Capital Anstalt
Rate: 8% per annum
Maturity: December 22, 2025
Event: incurrence

Exact text from the filing

Alpha Capital Anstalt (“Alpha”), pursuant to which it agreed to issue to Alpha, an 8% Senior Convertible Debenture (the “Debenture”) in the aggregate principal amount of $3,300,000 for a purchase price of $3,000,000. The Debenture will be convertible, at any time, and from time to time, at Alpha’s option, into shares of common stock of the Company (the

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AIxCrypto Holdings, Inc. entered into Securities Purchase Agreement with Alpha Capital Anstalt valued at $3,300,000 (effective 2022-12-21).

Action: entry
Agreement: equity purchase
Counterparty: Alpha Capital Anstalt
Value: $3,300,000
Effective: 2022-12-21

Exact text from the filing

On December 21, 2022, Qualigen Therapeutics, Inc. (the “Company”) entered into a Securities Purchase Agreement (“Agreement”) with Alpha Capital Anstalt (“Alpha”), pursuant to which it agreed to issue to Alpha, an 8% Senior Convertible Debenture (the “Debenture”) in the aggregate principal amount of $3,300,000 for a purchase price of $3,000,000.

View on SEC.gov

222 debt financings filed in the last 30 days. Browse all debt financings →

AIxCrypto Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-036302

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.